Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–34.
Banday MZ, Sameer AS, Nissar S. Pathophysiology of diabetes: an overview. Avicenna J Med. 2020;10(4):174–88.
Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34 Suppl 1(Suppl 1), S62–9.
Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–91.
Han SB, Yang HK, Hyon JY. Influence of diabetes mellitus on anterior segment of the eye. Clin Interv Aging. 2019;14:53–63.
Ferrara M, Loda A, Coco G, Grassi P, Cestaro S, Rezzola S, et al. Diabetic retinopathy: soluble and imaging ocular biomarkers. J Clin Med. 2023;12(3):912.
Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O’Neal DN, Januszewski AS. Biomarkers in diabetic retinopathy. Rev Diabet Stud. 2015;12(1–2):159–95.
Rizvi A, Rizvi F, Lalakia P, Hyman L, Frasso R, Sztandera L, et al. Is artificial intelligence the cost-saving lens to diabetic retinopathy screening in low- and middle-income countries? Cureus. 2023;15(9): e45539.
Hu W, Joseph S, Li R, Woods E, Sun J, Shen M, et al. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis. eClinicalMedicine. 2024;67:102387.
Vujosevic S, Aldington SJ, Silva P, Hernandez C, Scanlon P, Peto T, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020;8(4):337–47.
Abou Taha A, Dinesen S, Vergmann AS, Grauslund J. Present and future screening programs for diabetic retinopathy: a narrative review. Int J Retina Vitreous. 2024;10(1):14.
Hagan S, Martin E, Enríquez-de-Salamanca A. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine. Epma J. 2016;7(1):15.
Kaštelan S, Orešković I, Bišćan F, Kaštelan H, Gverović AA. Inflammatory and angiogenic biomarkers in diabetic retinopathy. Biochem Med (Zagreb). 2020;30(3): 030502.
Suárez-Cortés T, Merino-Inda N, Benitez-Del-Castillo JM. Tear and ocular surface disease biomarkers: a diagnostic and clinical perspective for ocular allergies and dry eye disease. Exp Eye Res. 2022;221: 109121.
Wong WKM, Polkamp M, Farr RJ, Kunte PS, Hardikar HP, Yajnik CS, et al. MicroRNA profiling from tears as a potential non-invasive method for early detection of diabetic retinopathy. Methods Mol Biol. 2023;2678:117–34.
Ponzini E. Tear biomarkers. Adv Clin Chem. 2024;120:69–115.
Król-Grzymała A, Sienkiewicz-Szłapka E, Fiedorowicz E, Rozmus D, Cieślińska A, Grzybowski A. Tear biomarkers in Alzheimer’s and Parkinson’s diseases, and multiple sclerosis: implications for diagnosis (systematic review). Int J Mol Sci. 2022;23(17):10123.
Khanna RK, Catanese S, Emond P, Corcia P, Blasco H, Pisella PJ. Metabolomics and lipidomics approaches in human tears: a systematic review. Surv Ophthalmol. 2022;67(4):1229–43.
Aydin E, Gokhale M, Azizoglu S, Suphioglu C. To see or not to see: a systematic review of the importance of human ocular surface cytokine biosignatures in ocular allergy. Cells. 2019;8(6):620.
Poon SHL, Cheung JJ, Shih KC, Chan YK. A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease. Rev Endocr Metab Disord. 2022;23(3):541–67.
Roda M, Corazza I, Bacchi Reggiani ML, Pellegrini M, Taroni L, Giannaccare G, et al. Dry eye disease and tear cytokine levels-a meta-analysis. Int J Mol Sci. 2020;21(9):3111.
Navel V, Malecaze J, Pereira B, Baker JS, Malecaze F, Sapin V, et al. Oxidative and antioxidative stress markers in keratoconus: a systematic review and meta-analysis. Acta Ophthalmol. 2021;99(6):e777–94.
Ponzini E, Scotti L, Grandori R, Tavazzi S, Zambon A. Lactoferrin concentration in human tears and ocular diseases: a meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(12):9.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.
Amorim M, Martins B, Caramelo F, Gonçalves C, Trindade G, Simão J, et al. Putative biomarkers in tears for diabetic retinopathy diagnosis. Front Med (Lausanne). 2022;9: 873483.
Costagliola C, Romano V, De Tollis M, Aceto F, dell’Omo R, Romano MR, et al. TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy. Mediators Inflamm. 2013;2013:629529.
Sheikhrezaee M, Alizadeh MR, Abediankenari S. The tear VEGF and IGFBP3 in healthy and diabetic retinopathy. Int Diabetes Dev Ctries. 2020;40(1):93–8.
Rohatgi A. WebPlotDigitizer Pacifica, CA, USA 2022;4.6. Available from: https://automeris.io/WebPlotDigitizer.
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000.
Julian PTH, Douglas GA, Peter CG, Peter J, David M, Andrew DO, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343: d5928.
Jonathan ACS, Miguel AH, Barnaby CR, Jelena S, Nancy DB, Meera V, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355: i4919.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Balduzzi S, Rücker G, G S. How to perform a meta-analysis with R: a practical tutorial. Evid-Based Mental Health. 2019;22:153–60.
Harrer M, Cuijpers P, Furukawa T, D ED. dmetar: companion R package for the guide ‘doing meta-analysis in R. 2019.
Harrer M, Cuijpers P, Furukawa TA, Ebert DD. Doing meta-analysis with R: a hands-on guide. 1st ed. Boca Raton, FL and London: Chapman & Hall/CRC Press; 2021. p. 2021.
Mei C, Pan L, Xu W, Xu H, Zhang Y, Li Z, et al. An ultrasensitive reusable aptasensor for noninvasive diabetic retinopathy diagnosis target on tear biomarker. Sens Actuators, B Chem. 2021;345: 130398.
Manchikanti V, Kasturi N, Rajappa M, Gochhait D. Ocular surface disorder among adult patients with type II diabetes mellitus and its correlation with tear film markers: a pilot study. Taiwan J Ophthalmol. 2021;11(2):156–60.
Byambajav M, Collier A, Shu X, Hagan S. Tear fluid biomarkers and quality of life in people with type 2 diabetes and dry eye disease. Metabolites. 2023;13(6):733.
Liu R, Ma B, Gao Y, Ma B, Liu Y, Qi H. Tear inflammatory cytokines analysis and clinical correlations in diabetes and nondiabetes with dry eye. Am J Ophthalmol. 2019;200:10–5.
Sorkhabi R, Ahoor Mh, Ghorbani Haghjo A, Tabei E, Taheri N. Assessment of tear inflammatory cytokines concentration in patients with diabetes with varying severity of involvement. Exp Eye Res. 2022;224: 109233.
Liu J, Shi B, He S, Yao X, Willcox MD, Zhao Z. Changes to tear cytokines of type 2 diabetic patients with or without retinopathy. Mol Vis. 2010;16:2931–8.
Azhan A, Zunaina E, Mahaneem M, Siti-Azrin AH. Comparison of VEGF level in tears post phacoemulsification between non-proliferative diabetic retinopathy and non-diabetic patients. J Diabetes Metab Disord. 2021;20(2):2073–9.
Kim AY, Moon JY, Jun RM, Kim HJ, Han KE. Ocular surface and tear cytokine changes after cataract surgery in patients with type 2 diabetes. Ocul Immunol Inflamm. 2023;31(8):1615–22.
Zhou T, Dou Z, Cai Y, Zhu D, Fu Y. Tear fluid progranulin as a noninvasive biomarker for the monitoring of corneal innervation changes in patients with type 2 diabetes mellitus. Transl Vis Sci Technol. 2024;13(7): 9.
Hashemi H, Ahmadi H, Rostami Z, Alishahi A, Heidari Z. The role of endothelial growth factor and tear levels in diabetic retinopathy in type 2 diabetes. Int Ophthalmol. 2024;44(1):143.
Machalińska A, Kuligowska A, Ziontkowska-Wrzałek A, Stroynowska B, Pius-Sadowska E, Safranow K, et al. The severity of diabetic retinopathy corresponds with corneal nerve alterations and ocular discomfort of the patient. Int J Mol Sci. 2024;25(11):6072.
Amil-Bangsa NH, Mohd-Ali B, Ishak B, Abdul-Aziz CNN, Ngah NF, Hashim H, et al. Total protein concentration and tumor necrosis factor α in tears of nonproliferative diabetic retinopathy. Optom Vis Sci. 2019;96(12):934–9.
Stolwijk TR, Kuizenga A, Van Haeringen NJ, Kijlstra A, Oosterhuis JA, Van Best JA. Analysis of tear fluid proteins in insulin-dependent diabetes mellitus. Acta Ophthalmol. 1994;72(3):357–62.
Zou X, Zhang P, Xu Y, Lu L, Zou H. Quantitative proteomics and weighted correlation network analysis of tear samples in type 2 diabetes patients complicated with dry eye. Proteomics Clin Appl. 2020;14(4): e1900083.
Yu L, Chen X, Qin G, Xie H, Lv P. Tear film function in type 2 diabetic patients with retinopathy. Ophthalmologica. 2008;222(4):284–91.
Ang WJ, Zunaina E, Norfadzillah AJ, Raja-Norliza RO, Julieana M, Ab-Hamid SA, et al. Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients. PLoS ONE. 2019;14(8): e0221481.
Zhou F, Zhao H, Chen K, Cao S, Shi Z, Lan M. Flexible electrochemical sensor with Fe/Co bimetallic oxides for sensitive analysis of glucose in human tears. Anal Chim Acta. 2023;1243: 340781.
Wang JC, Ku HY, Chen TS, Chuang HS. Detection of low-abundance biomarker lipocalin 1 for diabetic retinopathy using optoelectrokinetic bead-based immunosensing. Biosens Bioelectron. 2017;89(Pt 2):701–9.
Chuang HS, Chen YJ, Cheng HP. Enhanced diffusometric immunosensing with grafted gold nanoparticles for detection of diabetic retinopathy biomarker tumor necrosis factor-α. Biosens Bioelectron. 2018;101:75–83.
Chen LY, Hsu SM, Wang JC, Yang TH, Chuang HS. Photonic crystal enhanced immunofluorescence biosensor integrated with a lateral flow microchip: toward rapid tear-based diabetic retinopathy screening. Biomicrofluidics. 2023;17(4): 044102.
Yao J, Liu Y, Jiang B, Yuan R, Xiang Y. An aptamer triple helix molecular switch for sensitive electrochemical assay of lipocalin 1 biomarker via dual signal amplifications. Analyst. 2023;148(12):2739–44.
Guzman J, Hsu SM, Chuang HS. Colorimetric diagnostic capillary enabled by size sieving in a porous hydrogel. Biosensors (Basel). 2020;10(10):130.
Kim DW, Seo JH, Lim S-H. Evaluation of ocular surface disease in elderly patients with glaucoma: expression of matrix metalloproteinase-9 in tears. Eye. 2021;35(3):892–900.
Wang J-Y, Kwon J-S, Hsu S-M, Chuang H-S. Sensitive tear screening of diabetic retinopathy with dual biomarkers enabled using a rapid electrokinetic patterning platform. Lab Chip. 2020;20(2):356–62.
Chen W-L, Jayan M, Kwon J-S, Chuang H-S. Facile open-well immunofluorescence enhancement with coplanar-electrodes-enabled optoelectrokinetics and magnetic particles. Biosens Bioelectron. 2021;193: 113527.
Khan MS, Dighe K, Wang Z, Daza EA, Schwartz-Duval AS, Rowley CP, et al. Label-free detection of lactoferrin and beta-2-microglobuin in contrived tear film using a low-cost electrical biosensor chip. 2017 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT). 2017:72–5.
Phong PH, Chuang H-S, Thi Thuong D, Sang NN, Thi Ha Lien N, Nghia NT, et al. Graphene oxide-decorated hyrogel inverse opal photonic crystal improving colorimetric and fluorescent responses for rapid detection of lipocalin-1. Photonics and Nanostructures – Fundamentals and Applications. 2024;58: 101237.
Gomez A, Myrkhiyeva Z, Tilegen M, Pham T, Bekmurzayeva A, Tosi D. Optical fiber ball resonator biosensor as a platform for detection of diabetic retinopathy biomarkers in tears. IEEE Sens J. 2024;24:11127–35.
Youngblood H, Robinson R, Sharma A, Sharma S. Proteomic biomarkers of retinal inflammation in diabetic retinopathy. Int J Mol Sci. 2019;20(19):4755.
Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10): a016295.
Shrestha GS, Vijay AK, Stapleton F, Carnt NA. The effect of collection method on tear interleukin-6 levels in healthy individuals: a pilot study. Investigative Ophthalmology, Visual Science. 2019;60(9):5370-.
Ghasemi H, Ghazanfari T, Yaraee R, Faghihzadeh S, Hassan ZM. Roles of IL-8 in ocular inflammations: a review. Ocul Immunol Inflamm. 2011;19(6):401–12.
Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev. 2011;22(4):189–95.
Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42(10):2283–92.
Hallegua DS, Weisman MH. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis. 2002;61(11):960–7.
Taghavi Y, Hassanshahi G, Kounis NG, Koniari I, Khorramdelazad H. Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations. J Cell Commun Signal. 2019;13(4):451–62.
Hanstock HG, Edwards JP, Walsh NP. Tear lactoferrin and lysozyme as clinically relevant biomarkers of mucosal immune competence. Front Immunol. 2019;10:1178.
Semeraro F, Cancarini A, dell’Omo R, Rezzola S, Romano MR, Costagliola C. Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res. 2015;2015:582060.
Kim HJ, Kim PK, Yoo HS, Kim CW. Comparison of tear proteins between healthy and early diabetic retinopathy patients. Clin Biochem. 2012;45(1):60–7.
Gao S, Zhang S, Sun X, Zheng X, Wu J. Fluorescent aptasensor based on G-quadruplex-assisted structural transformation for the detection of biomarker lipocalin 1. Biosens Bioelectron. 2020;169: 112607.
O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Frontiers in Endocrinology. 2018;9:402.
Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, et al. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside. Target Oncol. 2020;15(3):261–78.
Ranganathan K, Sivasankar V. MicroRNAs – Biology and clinical applications. J Oral Maxillofac Pathol. 2014;18(2):229–34.
Joglekar MV, Parekh VS, Hardikar AA. New pancreas from old: microregulators of pancreas regeneration. Trends Endocrinol Metab. 2007;18(10):393–400.
Wong WKM, Sorensen AE, Joglekar MV, Hardikar AA, Dalgaard LT. Non-coding RNA in pancreas and beta-cell development. Noncoding RNA. 2018;4(4):41.
Pinazo-Durán MD, Zanón-Moreno V, Lleó-Perez A, García-Medina JJ, Galbis-Estrada C, Roig-Revert MJ, et al. Genetic systems for a new approach to risk of progression of diabetic retinopathy. Arch Soc Esp Oftalmol. 2016;91(5):209–16.
Chan HW, Yang B, Wong W, Blakeley P, Seah I, Tan QSW, et al. A pilot study on MicroRNA profile in tear fluid to predict response to anti-VEGF treatments for diabetic macular edema. J Clin Med. 2020;9(9):2920.
Torimura A, Kanei S, Shimizu Y, Baba T, Uotani R, Sasaki S-i, et al. Profiling miRNAs in tear extracellular vesicles: a pilot study with implications for diagnosis of ocular diseases. Japanese Journal of Ophthalmology. 2024;68(1):70–81.
Nattinen J, Aapola U, Jylha A, Vaajanen A, Uusitalo H. Comparison of capillary and Schirmer strip tear fluid sampling methods using SWATH-MS proteomics approach. Transl Vis Sci Technol. 2020;9(3): 16.
You J, Willcox MD, Madigan MC, Wasinger V, Schiller B, Walsh BJ, et al. Tear fluid protein biomarkers. Adv Clin Chem. 2013;62:151–96.
